LI-COR is the famous Corporate Investor, which was founded in 1971. The main office of represented Corporate Investor is situated in the Lincoln. The fund was located in North America if to be more exact in United States.
The high activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the LI-COR, startups are often financed by Ysios Capital, Lysosomal Therapeutics, Chiesi Ventures. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Lundbeckfonden Ventures, Columbus Venture Partners. In the next rounds fund is usually obtained by Medicxi Ventures.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Aura Biosciences. Among the most successful fund investment fields, there are Biotechnology, Health Care.
Fund Name | Location |
360networks | Seattle, United States, Washington |
42CAP | Bayern, Germany, Munich |
AGC | Japan, Tokyo |
Angel Labs | California, San Francisco, United States |
Binux Capital | California, Saratoga, United States |
Citi Foundation | - |
Diedai Capital | China, Hangzhou, Zhejiang |
Espace-inc | Canada, Quebec, Sherbrooke |
Grafton Capital | England, London, United Kingdom |
Green River Investments | - |
Jason Investment | China, Futian, Guangdong |
Lonza Group | Basel, Basel-Stadt, Switzerland |
New Amsterdam Capital | England, London, United Kingdom |
Nikkei Digital Media | Japan, Tokyo |
Pine Brook Partners | New York, New York, United States |
Pivotal Asset Management | California, San Francisco, United States |
Raytheon | Massachusetts, United States, Waltham |
Salem Investment Partners | Greensboro, North Carolina, United States |
Startech Early Ventures | Richardson, Texas, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Aura Biosciences | $30M | 21 Dec 2017 | Cambridge, Massachusetts, United States | ||
Aura Biosciences | $21M | 05 Mar 2015 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Aura Biosciences | $30M | 21 Dec 2017 | Cambridge, Massachusetts, United States | ||
Aura Biosciences | $21M | 05 Mar 2015 | Cambridge, Massachusetts, United States |